Literature DB >> 10416792

Vitrectomy in the management of diabetic retinopathy.

W E Smiddy1, H W Flynn.   

Abstract

According to the Early Treatment Diabetic Retinopathy Study, at least 5% of eyes receiving optimal medical treatment will still have progressive retinopathy that requires laser treatment and pars plana vitrectomy. During the past decade, improvements in instrumentation and surgical techniques have allowed more difficult cases of diabetic retinopathy to be candidates for vitrectomy. However, although the thresholds for performing surgery within established indicated situations have been lowered, only a few additional indications have been established. Although vitrectomy improves the prognosis for a favorable visual outcome, preventive measures, such as improved control of glucose levels and timely application of panretinal photocoagulation, produce better results. The authors review the indications, techniques, and results of vitrectomy in the management of diabetic retinopathy.

Entities:  

Mesh:

Year:  1999        PMID: 10416792     DOI: 10.1016/s0039-6257(99)00036-3

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  20 in total

Review 1.  Surgical treatment of diabetic retinopathy.

Authors:  Horst Helbig; Florian K P Sutter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

2.  Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.

Authors:  O Zeitz; M Keserü
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-06       Impact factor: 3.117

3.  Review of therapeutic advances in diabetic retinopathy.

Authors:  Chirag P Shah; Carolyn Chen
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

Review 4.  [Surgical treatment of diabetic retinopathy and maculopathy].

Authors:  A M Joussen; H Llacer; J Mazciewicz; B Kirchhof
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

5.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

6.  Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.

Authors:  H Funatsu; H Yamashita; H Noma; T Mimura; K Sakata; S Hori
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

7.  Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.

Authors: 
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

8.  Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.

Authors:  Brian J Raisler; Kenneth I Berns; Maria B Grant; Denis Beliaev; William W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-18       Impact factor: 11.205

Review 9.  Surgical management of diabetic retinopathy.

Authors:  Vishali Gupta; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

Review 10.  Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation.

Authors:  Qi Yu; Kun Liu; Li Su; Xin Xia; Xun Xu
Journal:  Biomed Res Int       Date:  2014-03-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.